State Street Corp Vista Gen Therapeutics, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.12 - $0.3 $32,310 - $80,775	269,252 Added 4.37%	6,432,023 $771,000
Q4 2022 Feb 14, 2023	BUY	$0.09 - $0.16 $47,763 - $84,912	530,705 Added 9.42%	6,162,771 $616,000
Q3 2022 Nov 15, 2022	BUY	$0.14 - $1.07 $243,133 - $1.86 Million	1,736,668 Added 44.58%	5,632,066 $857,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $251,291 - $494,015	285,558 Added 7.91%	3,895,398 $3.43 Million
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $5.69 Million - $10.4 Million	-4,990,394 Reduced 58.03%	3,609,840 $4.48 Million

Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $1.24 Million - $2.06 Million	745,095 Added 9.49%	8,600,234 $16.8 Million
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $12.6 Million - $16.5 Million	4,795,529 Added 156.74%	7,855,139 $21.5 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $6 Million - $9.64 Million	3,059,610 New	3,059,610 $9.64 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.